Tenelia Tab. 20mg

Ingredient

Teneligliptin Hydrobromide Hydrate

Content

Teneligliptin Hydrobromide Hydrate 31mg (20mg as Teneligliptin)

Indication

This drug is administered as an adjunct to diet and exercise to improve the glucose control of patients with type 2 diabetes.
1. This drug is administered as a monotherapy
2. This drug is administered as a combined therapy in the following case.
– This drug is administered as a combined therapy if sufficient glucose control cannot be achieved with metformin monotherapy.
– This drug is administered as a combined therapy if sufficient glucose control cannot be achieved with Metformin and Sulfonylurea combination therapy